MedPath
HSA Approval

JYNNEOS SUSPENSION FOR INJECTION

SIN17067P

JYNNEOS SUSPENSION FOR INJECTION

JYNNEOS SUSPENSION FOR INJECTION

August 23, 2024

AENON PHARMACEUTICALS SEA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAENON PHARMACEUTICALS SEA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SUSPENSION

SUBCUTANEOUS

Medical Information

J07BX01

Manufacturer Information

AENON PHARMACEUTICALS SEA PTE. LTD.

Bavarian Nordic A/S

Grand River Aseptic Manufacturing (Butterworth)

Active Ingredients

Modified Vaccinia Ankara - Bavarian Nordic (MVA-BN, live, non-replicating)

0.5 x 10^8 to 3.95 x 10^8 Inf. U /dose

Documents

Package Inserts

Jynneos Suspension for Injection PI.pdf

Approved: August 23, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

JYNNEOS SUSPENSION FOR INJECTION - HSA Approval | MedPath